Williamson Legacy Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.98M Buy
2,154
+114
+6% +$116K 1.49% 19
2025
Q4
$2.19M Sell
2,040
-107
-5% -$102K 1.71% 18
2025
Q3
$1.64M Sell
2,147
-8
-0.4% -$5.95K 1.27% 28
2025
Q2
$1.68M Buy
2,155
+32
+2% +$24.9K 1.42% 18
2025
Q1
$1.75M Sell
2,123
-54,451
-96% -$45.3M 1.66% 12
2024
Q4
$43.7M Sell
56,574
-100
-0.2% -$82.8K 29.11% 1
2024
Q3
$50.2M Buy
56,674
+13,694
+32% +$12.3M 33.56% 1
2024
Q2
$38.9M Buy
42,980
+101
+0.2% +$80.8K 28.95% 1
2024
Q1
$33.4M Sell
42,879
-104
-0.2% -$74K 25.84% 1
2023
Q4
$25.1M Buy
+42,983
New +$25.1M 23.23% 1

Other funds holding LLY

Williamson Legacy Group's LLY Position: Q1 2026 in Review

Williamson Legacy Group increased its Eli Lilly (LLY) stake by 5.6% in Q1 2026, buying an estimated $116K and bringing the position to 2,154 shares worth $1.98M. The position accounts for 1.49% of the portfolio, ranked #19.

Williamson Legacy Group first reported a position in LLY in Q4 2023 and has held it in 10 quarters since. The position peaked at $50.2M in Q3 2024. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Williamson Legacy Group held 2,154 shares of Eli Lilly worth $1.98M as of Q1 2026.
  • Williamson Legacy Group bought 114 Eli Lilly shares in Q1 2026, an estimated $116K.
  • Eli Lilly made up 1.49% of Williamson Legacy Group's portfolio in Q1 2026, its #19 holding.
  • Williamson Legacy Group first reported a position in Eli Lilly in Q4 2023 and has held it in 10 quarters since.
  • Williamson Legacy Group's Eli Lilly position peaked at $50.2M in Q3 2024.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Williamson Legacy Group's 13F filing for Q1 2026, filed 13 May 2026.